Multiple Lactobacillus Infections Caused by Probiotics at Pediatric and Adult Academic Medical Centers.

Allison M Samuel, Matthew G Lammers, Joshua Nachreiner, Monica C Bogenschutz, Kirsten Koffarnus, Lucas Schulz, Kristin A Shadman, Joseph A McBride
{"title":"Multiple <i>Lactobacillus</i> Infections Caused by Probiotics at Pediatric and Adult Academic Medical Centers.","authors":"Allison M Samuel, Matthew G Lammers, Joshua Nachreiner, Monica C Bogenschutz, Kirsten Koffarnus, Lucas Schulz, Kristin A Shadman, Joseph A McBride","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Probiotics are synthetic oral supplements containing live bacterial and fungal species hypothesized to help with various gastrointestinal conditions. However, they can cause infection if the organism spreads outside of the gastrointestinal tract. The aim of this study was to identify and describe patients who experienced systemic infections caused by probiotic use.</p><p><strong>Methods: </strong>This study was a retrospective chart review of pediatric and adult patients at academic medical centers who received probiotics and subsequently developed positive cultures from a sterile site for probiotic-related species. Two individuals completed the chart reviews to determine if the probiotic was the true cause of the infection.</p><p><strong>Results: </strong><i>Lactobacillus</i>, <i>Bifidobacterium</i>, and <i>Saccharomyces</i> cultures were reviewed, with a total of 71, 8, and 2 cultures isolated from sterile sites for each organism, respectively. Further review revealed 23 <i>Lactobacillus</i> cultures from 13 unique patients who were taking <i>Lactobacillus</i>-containing probiotics. Four patients without gastrointestinal tract compromise were included in the final analysis, including 1 patient whose culture was confirmed as identical to the probiotic. Types of infections included meningitis and bacteremia. Targeted antimicrobial therapy included ampicillin, ampicillin-sulbactam, and piperacillin-tazobactam, with total durations of therapy ranging from 10 to 22 days. No patients had mortality attributed to <i>Lactobacillus</i> infection.</p><p><strong>Conclusions: </strong>Probiotics are not harmless supplements as they come with risk of serious infection as demonstrated in this review. Before use, the risks of probiotics should be considered carefully for each individual patient. Clinicians should consider avoiding probiotics in hospitalized patients, especially those with vascular or extra-ventricular access devices.</p>","PeriodicalId":94268,"journal":{"name":"WMJ : official publication of the State Medical Society of Wisconsin","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"WMJ : official publication of the State Medical Society of Wisconsin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Probiotics are synthetic oral supplements containing live bacterial and fungal species hypothesized to help with various gastrointestinal conditions. However, they can cause infection if the organism spreads outside of the gastrointestinal tract. The aim of this study was to identify and describe patients who experienced systemic infections caused by probiotic use.

Methods: This study was a retrospective chart review of pediatric and adult patients at academic medical centers who received probiotics and subsequently developed positive cultures from a sterile site for probiotic-related species. Two individuals completed the chart reviews to determine if the probiotic was the true cause of the infection.

Results: Lactobacillus, Bifidobacterium, and Saccharomyces cultures were reviewed, with a total of 71, 8, and 2 cultures isolated from sterile sites for each organism, respectively. Further review revealed 23 Lactobacillus cultures from 13 unique patients who were taking Lactobacillus-containing probiotics. Four patients without gastrointestinal tract compromise were included in the final analysis, including 1 patient whose culture was confirmed as identical to the probiotic. Types of infections included meningitis and bacteremia. Targeted antimicrobial therapy included ampicillin, ampicillin-sulbactam, and piperacillin-tazobactam, with total durations of therapy ranging from 10 to 22 days. No patients had mortality attributed to Lactobacillus infection.

Conclusions: Probiotics are not harmless supplements as they come with risk of serious infection as demonstrated in this review. Before use, the risks of probiotics should be considered carefully for each individual patient. Clinicians should consider avoiding probiotics in hospitalized patients, especially those with vascular or extra-ventricular access devices.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿科和成人学术医疗中心使用益生菌引起的多种乳酸杆菌感染。
背景:益生菌是一种人工合成的口服补充剂,含有活细菌和真菌物种,据推测有助于治疗各种胃肠道疾病。然而,如果益生菌扩散到胃肠道之外,就会引起感染。本研究旨在识别和描述因使用益生菌而导致全身感染的患者:本研究对学术医疗中心的儿童和成人患者进行了回顾性病历审查,这些患者接受了益生菌治疗,随后无菌部位的益生菌相关菌种培养呈阳性。两人完成了病历审查,以确定益生菌是否是感染的真正原因:结果:对乳酸杆菌、双歧杆菌和酵母菌培养物进行了复查,从无菌部位分离出的每种生物的培养物总数分别为 71、8 和 2 个。进一步审查发现,有 13 名患者服用了含乳酸杆菌的益生菌,他们共培养出 23 个乳酸杆菌。最终分析包括四名没有胃肠道感染的患者,其中一名患者的培养物被证实与益生菌相同。感染类型包括脑膜炎和菌血症。针对性抗菌治疗包括氨苄西林、氨苄西林-舒巴坦和哌拉西林-他唑巴坦,总治疗时间为 10-22 天。没有患者因乳酸杆菌感染而死亡:本综述表明,益生菌并非无害的补充剂,因为它们存在严重感染的风险。在使用益生菌之前,应仔细考虑每位患者的风险。临床医生应考虑避免在住院患者中使用益生菌,尤其是那些有血管或心室外通路装置的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
STRN-ALK Fusion in Advanced Salivary Gland Carcinoma With Response to Anaplastic Lymphoma Kinase Inhibition: Case Report and Literature Review. Community Agency Preferences for and Perceptions of Disseminating and Implementing a Continence Promotion Program. Delta-8 Tetrahydrocannabinol in the Emergency Department: A Case Series. Driving in Cars with Viral Transport Medium. Experience as IMGs Applying for US Clinical Experience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1